Chad M Robins
Director, CEO and Chairman · 6 filings · Latest: Aug 17, 2026
Adaptive Biotechnologies Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADPT | Chad Robins | — | Jan 5, 2026 | Proposed Sale | $16.17 | 124,998 | $2.0M | — | |
ADPT | Chad Robins | — | Dec 1, 2025 | Proposed Sale | $18.84 | 124,998 | $2.4M | — | |
ADPT | Chad Robins | — | Nov 26, 2025 | Proposed Sale | $19.72 | 35,736 | $704.7K | — | |
ADPT | Chad Robins | — | Nov 12, 2025 | Proposed Sale | $14.50 | 1,876 | $27.2K | — | |
ADPT | Chad Robins | — | Nov 11, 2025 | Proposed Sale | $14.53 | 1,237 | $18.0K | — | |
ADPT | Chad Robins | — | Nov 10, 2025 | Proposed Sale | $14.71 | 86,161 | $1.3M | — |
← Previous
Page 2 of 2